Bioxytech Retina
Bioxytech Retina, founded in 2015, pioneers non-invasive optical devices for diabetes diagnosis.
Founded
2015Bioxytech Retina, founded in 2015, pioneers non-invasive optical devices for diabetes diagnosis.
Bioxytech Retina, founded in 2015 and based in Richmond, California, is dedicated to pioneering non-invasive optical devices for the diagnosis of diabetes. The company’s core mission is to leverage advanced imaging technology to detect diabetic retinopathy, a leading cause of vision loss among diabetes patients. Bioxytech Retina offers free eye exams and monitoring services, aiming to provide early detection and comprehensive eye health consultations to mitigate the effects of this condition.
Notably, Bioxytech Retina collaborates with a world-class expert in retinal disorders who supervises patient examinations and provides detailed consultations. The company has achieved significant milestones by integrating cutting-edge optical research into practical healthcare solutions, positively impacting the early diagnosis and management of diabetic retinopathy. This proactive approach not only enhances patient outcomes but also contributes to broader public health efforts in managing diabetes-related complications.
Companies similar to Bioxytech Retina include Envision Diagnostics, Intelligent Retinal Imaging Systems, Retina Technologies and Vitreoretinal Technologies.
Bioxytech Retina was founded in 2015.
Bioxytech Retina's headquarters is located in Richmond, CA, US.
Bioxytech Retina's most recent funding round was for $981.5k (USD) in March 2019.
As of Mar 1, 2019, Bioxytech Retina has disclosed funding of $1.2M (USD). Undisclosed round amounts are excluded.
Bioxytech Retina has 5 employees as of Feb 4, 2024.
Vitreoretinal Technologies
